LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "mutated gliomas" as a keyword



BOLD Asynchrony Elucidates Tumor Burden in IDH-Mutated Gliomas.

Sign Up to like & get
recommendations! Published in 2021 at "Neuro-oncology"

DOI: 10.1093/neuonc/noab154

Abstract: BACKGROUND Gliomas comprise the most common type of primary brain tumor, are highly invasive, and often fatal. IDH-mutated gliomas are particularly challenging to image and there is currently no clinically accepted method for identifying the… read more here.

Keywords: mutated gliomas; bold asynchrony; tumor burden; idh mutated ... See more keywords

P06.10.B POSTOPERATIVE COGNITIVE TRAJECTORY OF PATIENTS WITH GIANT IDH MUTATED GLIOMAS

Sign Up to like & get
recommendations! Published in 2025 at "Neuro-Oncology"

DOI: 10.1093/neuonc/noaf193.242

Abstract: IDH mutated gliomas are in many instances causing cognitive impairment already at time of diagnosis. In addition, the treatment may also cause cognitive decline. The negative cognitive impact may potentially be higher in the largest… read more here.

Keywords: mutated gliomas; giant idh; idh mutated; patients giant ... See more keywords

Reliable cognitive changes the first year following guideline-based treatment of IDH mutated gliomas: a longitudinal multicenter study.

Sign Up to like & get
recommendations! Published in 2025 at "Neuro-oncology"

DOI: 10.1093/neuonc/noaf263

Abstract: BACKGROUND Management of isocitrate dehydrogenase (IDH) mutated gliomas is multidisciplinary and current guidelines support early multimodal treatment. The effects of this treatment approach on cognition are less studied. We aimed to study changes in cognitive functioning… read more here.

Keywords: mutated gliomas; year; treatment; idh mutated ... See more keywords

Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.

Sign Up to like & get
recommendations! Published in 2017 at "Cancer research"

DOI: 10.1158/0008-5472.can-16-2773

Abstract: Mutations in isocitrate dehydrogenase (IDH) are the most prevalent genetic abnormalities in lower grade gliomas. The presence of these mutations in glioma is prognostic for better clinical outcomes with longer patient survival. In the present… read more here.

Keywords: idh1 mutated; mutated gliomas; dna repair; repair ... See more keywords